Nuveen LLC purchased a new stake in shares of Investors Title Company (NASDAQ:ITIC - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,573 shares of the insurance provider's stock, valued at approximately $861,000. Nuveen LLC owned approximately 0.16% of Investors Title as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in Investors Title in the fourth quarter worth approximately $222,000. Wells Fargo & Company MN raised its stake in Investors Title by 20.1% in the fourth quarter. Wells Fargo & Company MN now owns 1,127 shares of the insurance provider's stock worth $267,000 after buying an additional 189 shares in the last quarter. Deutsche Bank AG raised its stake in Investors Title by 33.6% in the fourth quarter. Deutsche Bank AG now owns 1,448 shares of the insurance provider's stock worth $343,000 after buying an additional 364 shares in the last quarter. Invesco Ltd. raised its stake in Investors Title by 55.6% in the first quarter. Invesco Ltd. now owns 1,559 shares of the insurance provider's stock worth $376,000 after buying an additional 557 shares in the last quarter. Finally, Citadel Advisors LLC bought a new position in Investors Title in the fourth quarter worth approximately $513,000. Institutional investors own 41.40% of the company's stock.
Analysts Set New Price Targets
Separately, Wall Street Zen lowered shares of Investors Title from a "buy" rating to a "hold" rating in a report on Monday, May 12th.
Check Out Our Latest Report on Investors Title
Investors Title Price Performance
NASDAQ ITIC traded down $3.26 on Friday, hitting $251.73. The stock had a trading volume of 19,550 shares, compared to its average volume of 27,877. The business's fifty day moving average price is $224.14 and its 200 day moving average price is $226.64. Investors Title Company has a 52-week low of $190.20 and a 52-week high of $290.40. The stock has a market cap of $475.77 million, a price-to-earnings ratio of 14.40 and a beta of 0.87.
Investors Title (NASDAQ:ITIC - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The insurance provider reported $6.48 earnings per share (EPS) for the quarter. Investors Title had a net margin of 12.28% and a return on equity of 12.70%.
Investors Title Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd will be issued a dividend of $0.46 per share. The ex-dividend date of this dividend is Tuesday, September 2nd. This represents a $1.84 dividend on an annualized basis and a dividend yield of 0.7%. Investors Title's payout ratio is 10.53%.
Investors Title Profile
(
Free Report)
Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.
See Also

Before you consider Investors Title, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Investors Title wasn't on the list.
While Investors Title currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.